Is Wall Street Bullish or Bearish on Zimmer Biomet Stock?

Valued at $22.1 billion by market cap, Zimmer Biomet Holdings, Inc. (ZBH) is a medical technology company specializing in designing, manufacturing, and marketing orthopedic reconstructive products. The Warsaw, Indiana-situated company caters to orthopedic surgeons, neurosurgeons, hospitals, and healthcare distributors.

The medical device giant has struggled to keep up with the broader market over the past year. Over the past 52 weeks, ZBH dipped 2.9% compared to the S&P 500 Index’s ($SPX) 30.1% returns. In 2024 alone, ZBH is down 10.2% versus SPX’s 24.1% gains on a YTD basis.